CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

Abroad (travel likely)RecruitingPHASE2

Conditions

Fontan Circulation · Single Ventricle Heart Disease · HFpEF - Heart Failure With Preserved Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Luke Burchill, M.B.B.S., Ph.D.)

Study leads

Luke Burchill, M.B.B.S., Ph.D.
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease

Fontan Circulation

Abroad (travel likely)RecruitingPHASE1

Kansas City, United States

Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation

Univentricular Heart · Microvascular Dysfunction · Heart Failure

Abroad (travel likely)Recruiting

Stockholm, Sweden

Fontan Circulation and Reproductive Health in a National Swedish Cohort

Fontan Circulation

Abroad (travel likely)Recruiting

Lund, Sweden · Gothenburg, Sweden